imugene get huge wrap.sp predict $1.09, page-6

The chart and their screw-up of the bird virus shows how amateurish this company is.
Secondly, look at how much money they spent on research in the last quarter -under $60k from memory, and I think they supposedly developing about 10 different products. They are all in the very early stages of development, and the development is gonna be real slow at $200k per year being invested in them.
I've followed biotech's for many years and the majority of my portfolio, is and always has been biotechs, and sorry to say, but this one is utter crap.